Solid Biosciences (SLDB) Enterprise Value Growth (1y) (2018 - 2026)
Solid Biosciences (SLDB) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.36% |
| Dec 31, 2025 | -134.12% |
| Sep 30, 2025 | -38.00% |
| Jun 30, 2025 | -40.91% |
| Mar 31, 2025 | -2.21% |
| Dec 31, 2024 | 35.11% |
| Sep 30, 2024 | -19.76% |
| Jun 30, 2024 | -18.77% |
| Mar 31, 2024 | -11.08% |
| Dec 31, 2023 | 42.15% |
| Sep 30, 2023 | -191.44% |
| Jun 30, 2023 | -193.67% |
| Mar 31, 2023 | -3.03% |
| Dec 31, 2022 | -2.86% |
| Sep 30, 2022 | 55.33% |
| Jun 30, 2022 | 72.82% |
| Mar 31, 2022 | 32.94% |
| Dec 31, 2021 | -33.99% |
| Sep 30, 2021 | -342.66% |
| Jun 30, 2021 | -392.30% |